Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Endocrine ; 11(3): 257-67, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10786822

RESUMO

The effect of estrogen (E) and progesterone (P) on the protein expression of the rate-limiting enzyme in serotonin synthesis, tryptophan hydroxylase (TPH), and the level of serotonin in the hypothalamic terminal field was examined in guinea pigs. In addition, we questioned whether serotonin neurons of guinea pigs contain ovarian steroid receptors (estrogen receptoralpha[ERalpha], estrogen receptor beta[ERbeta], progestin receptors [PRs]) that could directly mediate the actions of E or P. Western blot and densitometric analysis for TPH were used on raphe extracts from untreated-ovariectomized (OVX), OVX-E-treated (28 d), and OVX-E+P-treated (14 d E+14 d E+P) guinea pigs. The medial basal hypothalami from the same animals were extracted and subjected to high-performance liquid chromatography analysis for serotonin, dopamine, 5-hydroxyindole acetic acid, and homovanillic acid. The brains from other animals treated in an identical manner were perfusion fixed and examined for the colocalization of ERalpha plus serotonin and PR plus serotonin with double immunohistochemistry or for expression of ERbeta mRNA with in situ hybridization. E and E+P treatment significantly increased TPH protein levels compared to the untreated control group (p < 0.05), but TPH levels were similar in the E and E+P-treated groups. By contrast, serotonin (nanogram/milligram of protein) in the hypothalamus was significantly increased by E+P treatment, but not by E alone. Neither ERalpha nor PR proteins were detected within serotonin neurons of the guinea pig raphe nucleus. However, ERbeta mRNA was expressed in the dorsal raphe. In summary, E alone increased TPH protein expression and the addition of P had no further effect, whereas E+P increased hypothalamic serotonin and E alone had no effect. The localization of ERbeta, but not ERalpha or PR, in the dorsal raphe nucleus suggests that E acting via ERbeta within serotonin neurons increases expression of TPH, but that P acting via other neurons and transsynaptic stimulation may effect changes in TPH enzymatic activity, which in turn, would lead to an increase in serotonin synthesis.


Assuntos
Estrogênios/farmacologia , Mesencéfalo/química , Progesterona/farmacologia , Receptores de Esteroides/análise , Serotonina/metabolismo , Triptofano Hidroxilase/metabolismo , Animais , Monoaminas Biogênicas/análise , Western Blotting , Receptor alfa de Estrogênio , Receptor beta de Estrogênio , Estrogênios/sangue , Feminino , Cobaias , Hipotálamo/química , Tamanho do Órgão , Ovariectomia , Hipófise/anatomia & histologia , Progesterona/sangue , RNA Mensageiro/análise , Núcleos da Rafe/química , Receptores de Estrogênio/análise , Receptores de Estrogênio/genética , Receptores de Estrogênio/fisiologia , Receptores de Progesterona/análise , Receptores de Progesterona/fisiologia
2.
Cancer Lett ; 6(2): 83-7, 1979 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-35280

RESUMO

The mutagenicity of a non-carcinogenic nitrosamine, N,N-dibenzylnitrosamine (I), and a chemically synthesized alpha-acetoxy derivative, N-(alpha-acetoxy-benzyl)-N-benzylnitrosamine (II), has been examined in Salmonella typhimurium TA100 and TA1535. Compound (I) was non-mutagenic when tested directly or in the presence of a metabolic activation system while (II) was highly mutagenic when tested directly. This is the first report on the conversion of a non-mutagenic N-nitrosamine to a mutagen by the formation of an alpha-acetoxy derivative.


Assuntos
Mutagênicos , Nitrosaminas/farmacologia , Animais , Compostos de Benzil/farmacologia , Biotransformação , Avaliação Pré-Clínica de Medicamentos/métodos , Técnicas In Vitro , Microssomos Hepáticos/metabolismo , Mutagênicos/metabolismo , NADP/metabolismo , Nitrosaminas/metabolismo , Ratos , Salmonella typhimurium/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA